metastatic 

71770
单词释义
adj.转移的;迁徙的;转移性的;由转移所致的;变形的;新陈代谢的
词根词缀记忆/谐音联想记忆 补充/纠错
单词例句
Metastatic breast cancer had spread to her bones.
转移性乳腺癌已经扩散到她的骨骼。
The patient was diagnosed with metastatic lung cancer that originated from the primary site in his pancreas.
患者被诊断出由胰腺原发部位引发的转移性肺癌。
Metastatic melanoma can be challenging to treat, as it often spreads to other organs rapidly.
转移性黑色素瘤治疗起来颇具挑战,因为它通常会迅速扩散至其他器官。
He was admitted to the hospital due to brain metastases from his renal cell carcinoma.
他因肾细胞癌引起的脑转移瘤而入院。
Surgery is not an option for most patients with widespread metastatic disease.
对于大多数广泛转移疾病的患者来说,手术并非治疗选择。
Chemotherapy is often used to manage symptoms and slow the progression of metastatic colorectal cancer.
化疗常常用于缓解症状并延缓转移性结直肠癌的发展进程。
The doctor explained that the patient's liver lesions were consistent with metastatic ovarian cancer.
医生解释说,患者的肝脏病变与转移性卵巢癌一致。
Immunotherapy has shown promise in treating some types of metastatic cancer.
免疫疗法在治疗某些类型的转移性癌症方面展现出前景。
A biopsy confirmed that the patient's lymph node enlargement was caused by metastatic prostate cancer.
活检确认了患者的淋巴结肿大是由转移性前列腺癌引起的。
Despite advancements in medicine, the five-year survival rate for metastatic gastric cancer remains low.
尽管医学取得进步,但转移性胃癌的五年生存率仍然较低。
The first six indications, including as a treatment for unresectable or metastatic melanoma after the failure of standard systemic therapy, have been included in the 2023 edition of the national reimbursement drug list.
前六个适应症,包括标准全身治疗失败后不可切除或转移性黑色素瘤的治疗,已被列入2023年版的国家报销药物清单。
The Chinese biotech and its US partner Coherus BioSciences Inc jointly announced on Oct 27 that the US FDA approved Loqtorzi (toripalimab-tpzi) in combination with other drugs for the first-line treatment of adults with metastatic or recurrent locally advanced metastatic nasopharyngeal carcinoma (NPC), and as monotherapy for the treatment of adults with recurrent, or metastatic NPC with disease progression on or after platinum-containing chemotherapy.
10月27日,中国生物技术公司及其美国合作伙伴Cohereus BioSciences Inc联合宣布,美国FDA批准Loqtorzi(托帕利单抗-tpzi)与其他药物联合用于成人转移性或复发性局部晚期转移性鼻咽癌(NPC)的一线治疗,或在含铂化疗时或之后具有疾病进展的转移性NPC。
According to the approval released on Friday, the injected drug shall be used in combination with other medicines for first-line treatment of unresectable, locally advanced, recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma.
根据周五发布的批准,注射药物应与其他药物联合使用,用于不可切除、局部晚期、复发或转移性胃或胃食管交界腺癌的一线治疗。
Biopharmaceutical companyxa0Pfizer announced on Friday that Lorbrena, the world's first third-generation anaplastic lymphoma kinase inhibitor, has been approved by China's National Medical Products Administration for the treatment of patients with ALK-positive locally advanced or metastatic non-small cell lung cancer.
生物制药公司xa0Pfizer周五宣布,世界上第一种第三代间变性淋巴瘤激酶抑制剂Lorbrena已被中国国家药品监督管理局批准用于治疗ALK阳性的局部晚期或转移性癌症患者。
According to company sources, phase-III global clinical trials of another drug, fruquintinib, which was approved for the treatment of metastatic colorectal cancer in China, has completed patient recruitment in 14 countries, and the results are expected to be published within this year.
据该公司消息人士透露,另一种药物fruquintinib的III期全球临床试验已在14个国家完成了患者招募,预计将在今年内公布结果。该药物已在中国获批用于治疗转移性结直肠癌癌症。
The trial will enroll approximately 680 patients with metastatic colorectal cancer in the US, Europe and Japan, he said.
他称,这项试验将在美国、欧洲和日本招募大约680名患有转移性结肠癌的病人。
As a treatment for metastatic pancreatic cancer, liposome irinotecan is already available in many countries and regions including the United States, Europe, Korea and Japan.
脂质体伊立替康作为治疗转移性胰腺癌的药物,已经在包括美国、欧洲、韩国和日本在内的许多国家和地区上市。
Shanghai Fosun Pharmaceutical Group Co Ltd announced on Sunday its experimental drug ORIN1001 has received fast-track designation from the US Food and Drug Administration for the treatment of patients with relapsed, refractory and metastatic breast cancer, including triple-negative breast cancer, or TNBC.
The new drug is for the treatment of advanced solid tumors and relapsed refractory metastatic breast cancer.
It is an opportunity to bring our pharmaceutical scientists, medical device scientists, and even our consumer behavior scientists together to see how could we discourage people from smoking in the first place, detect cancer earlier in the metastatic process, and bring about more holistic approaches combining therapeutic and surgical intervention at the right time and place to ultimately find a way to care for lung cancer comprehensively.
At the heart of the deal is Dendreon's lead product, Provenge, the only cellular immunotherapy approved so far by the US Food and Drug Administration (FDA) for treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).
In April, China's National Medical Products Administration approved the company's anti-PD-1 antibody tislelizumab as a treatment for patients with locally advanced or metastatic urothelial carcinoma, the most common type of bladder cancer, following the therapy's initial approval in classic Hodgkin's lymphoma in December 2019.
在4月,中国国家药品监督管理局批准了该公司的抗PD-1抗体tislelizumab用于治疗局部晚期或转移性尿路上皮癌(最常见的膀胱癌)的患者,此前该疗法于2019年12月首次被批准用于经典霍奇金淋巴瘤。
Tislelizumab received approval from the China National Medical Products Administration last April as a treatment for patients with locally advanced or metastatic urothelial carcinoma, the most common type of bladder cancer, following the therapy's initial approval in classical Hodgkin's lymphoma by the NMPA in December 2019.
China's biotechnology company BeiGene Ltd announced on Saturday that its anti-PD-1 antibody tislelizumab, an immunotherapy, had received approval from the China National Medical Products Administration as a treatment for patients with locally advanced or metastatic urothelial carcinoma (UC), the most common type of bladder cancer, following the therapy's initial approval in classical Hodgkin's lymphoma by the NMPA in December.
The newly approved indication, for patients suffering from locally advanced or metastatic urothelial carcinoma with PD-L1 high expression whose disease progressed during or following platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy, is the first in a solid tumor indication.
未经许可,严禁转发。QQ交流群:688169419
0
0